26402072|t|Matrix Metalloproteinases in Alzheimer's Disease and Concurrent Cerebral Microbleeds.
26402072|a|Matrix metalloproteinases (MMPs) are a family of enzymes able to degrade components of the extracellular matrix, which is important for normal blood-brain barrier function. Their function is regulated by tissue inhibitors of matrix metalloproteinases (TIMPs). We investigated whether MMPs and TIMPs in cerebrospinal fluid (CSF) and plasma were altered in Alzheimer's disease (AD) and vascular dementia (VaD), and whether this effect was modified by presence of cerebral micro-bleeds in AD patients. In addition, we assessed associations of MMPs and TIMPs with CSF amyloid-beta(1-42) (Abeta42), tau, and tau phosphorylated at threonine-181 (p-tau). We measured MMP2, MMP9, and MMP10, and TIMP1 and TIMP2 in CSF and plasma of 52 AD patients, 26 matched controls, and 24 VaD patients. AD patients showed higher plasma MMP2 levels compared to VaD patients (p <  0.05), and higher CSF MMP10 levels compared to controls (p <  0.05). Microbleeds in AD were associated with lower CSF TIMP1, TIMP2 and MMP9 in a dose-response relation. In addition, CSF MMP2 was associated with p-tau (St.B 0.23, p <  0.05), and CSF MMP10 with tau (St.B 0.38, p <  0.001) and p-tau (St.B 0.40, p <  0.001). Our findings suggest involvement of MMP2 and MMP10 in AD pathology. Lower levels of TIMPs in AD patients with microbleeds suggest less MMP inhibition in patients with concurrent cerebral microbleeds, which may hypothetically lead to a more vulnerable blood-brain barrier in these patients.
26402072	29	48	Alzheimer's Disease	Disease	MESH:D000544
26402072	64	84	Cerebral Microbleeds	Disease	MESH:D002547
26402072	441	460	Alzheimer's disease	Disease	MESH:D000544
26402072	462	464	AD	Disease	MESH:D000544
26402072	470	487	vascular dementia	Disease	MESH:D015140
26402072	489	492	VaD	Disease	MESH:D015140
26402072	547	568	cerebral micro-bleeds	Disease	MESH:C536681
26402072	572	574	AD	Disease	MESH:D000544
26402072	575	583	patients	Species	9606
26402072	670	677	Abeta42	Gene	351
26402072	680	683	tau	Gene	4137
26402072	689	692	tau	Gene	4137
26402072	746	750	MMP2	Gene	4313
26402072	752	756	MMP9	Gene	4318
26402072	762	767	MMP10	Gene	4319
26402072	773	778	TIMP1	Gene	7076
26402072	783	788	TIMP2	Gene	7077
26402072	813	815	AD	Disease	MESH:D000544
26402072	816	824	patients	Species	9606
26402072	854	857	VaD	Disease	MESH:D015140
26402072	858	866	patients	Species	9606
26402072	868	870	AD	Disease	MESH:D000544
26402072	871	879	patients	Species	9606
26402072	901	905	MMP2	Gene	4313
26402072	925	928	VaD	Disease	MESH:D015140
26402072	929	937	patients	Species	9606
26402072	966	971	MMP10	Gene	4319
26402072	1013	1024	Microbleeds	Disease	
26402072	1028	1030	AD	Disease	MESH:D000544
26402072	1062	1067	TIMP1	Gene	7076
26402072	1069	1074	TIMP2	Gene	7077
26402072	1079	1083	MMP9	Gene	4318
26402072	1130	1134	MMP2	Gene	4313
26402072	1193	1198	MMP10	Gene	4319
26402072	1204	1207	tau	Gene	4137
26402072	1303	1307	MMP2	Gene	4313
26402072	1312	1317	MMP10	Gene	4319
26402072	1321	1323	AD	Disease	MESH:D000544
26402072	1360	1362	AD	Disease	MESH:D000544
26402072	1363	1371	patients	Species	9606
26402072	1377	1388	microbleeds	Disease	
26402072	1420	1428	patients	Species	9606
26402072	1445	1465	cerebral microbleeds	Disease	MESH:D002547
26402072	1547	1555	patients	Species	9606
26402072	Positive_Correlation	MESH:D000544	4313
26402072	Association	MESH:D000544	4318
26402072	Association	MESH:D000544	4319
26402072	Association	MESH:D000544	7076
26402072	Association	MESH:D000544	7077

